Weiss Ratings Reaffirms Sell (E+) Rating for 22nd Century Group (NASDAQ:XXII)

22nd Century Group (NASDAQ:XXII)‘s stock had its “sell (e+)” rating reiterated by equities researchers at Weiss Ratings in a report released on Saturday,Weiss Ratings reports.

Separately, StockNews.com lowered shares of 22nd Century Group from a “hold” rating to a “sell” rating in a research note on Tuesday, December 31st.

22nd Century Group Trading Down 7.6 %

XXII opened at $1.71 on Friday. The firm has a market capitalization of $2.94 million, a P/E ratio of 0.00 and a beta of 1.67. The firm’s 50 day moving average is $3.40 and its 200-day moving average is $12.53. 22nd Century Group has a 52-week low of $1.68 and a 52-week high of $581.85. The company has a quick ratio of 0.93, a current ratio of 1.09 and a debt-to-equity ratio of 1.59.

Institutional Trading of 22nd Century Group

A hedge fund recently bought a new stake in 22nd Century Group stock. Anson Funds Management LP purchased a new position in 22nd Century Group, Inc. (NASDAQ:XXII) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned about 6.77% of 22nd Century Group at the end of the most recent quarter. 18.06% of the stock is currently owned by institutional investors.

About 22nd Century Group

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.